Treatment of insomnia

Psychiatry

Volumn 6, Issue 7, 2007, Pages 301-304

  Wilson, Sue ^a   Nutt, David ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

benzodiazepines; insomnia; sleep; zolpidem; zopiclone

Indexed keywords

4 AMINOBUTYRIC ACID; ALPRAZOLAM; ANTIDEPRESSANT AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CHLORAL HYDRATE; CLOMETHIAZOLE; CLONAZEPAM; DIAZEPAM; HYPNOTIC SEDATIVE AGENT; LOPRAZOLAM; LORAZEPAM; LORMETAZEPAM; MELATONIN; MIRTAZAPINE; NITRAZEPAM; OXAZEPAM; PROMETHAZINE; TEMAZEPAM; ZALEPLON; ZOLPIDEM; ZOPICLONE;

ANXIETY; COGNITIVE THERAPY; DAYTIME SOMNOLENCE; DRUG ELIMINATION; HUMAN; INSOMNIA; PARASOMNIA; PRIORITY JOURNAL; REVIEW; SLEEP DISORDER; SLEEP PATTERN;

EID: 34347258835     PISSN: 14761793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mppsy.2007.04.009     Document Type: Review

References (11)

1. Leger D., Massuel M.A., and Metlaine A. Professional correlates of insomnia. Sleep 29 (2006) 171-178
2. Sateia M.J., and Nowell P.D. Insomnia. Lancet 364 (2004) 1959-1973
3. National Institutes of Health State of the Science conference statement on manifestations and management of chronic insomnia in adults, June 13-15, 2005. Sleep 28 (2005) 1049-1057
4. Krakow B., Hollifield M., Johnston L., et al. Imagery rehearsal therapy for chronic nightmares in sexual assault survivors with posttraumatic stress disorder: a randomized controlled trial. JAMA 286 (2001) 537-545
5. Dundar Y., Dodd S., Strobl J., et al. Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis. Hum Psychopharmacol 19 (2004) 305-322
6. Montplaisir J., Hawa R., Moller H., et al. Zopiclone and zaleplon vs benzodiazepines in the treatment of insomnia: Canadian consensus statement. Hum Psychopharmacol 18 (2003) 29-38
7. Nowell P.D., Mazumdar S., Buysse D.J., et al. Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. JAMA 278 (1997) 2170-2177
8. Buscemi N., Vandermeer B., Hooton N., et al. The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis. J Gen Intern Med 20 (2005) 1151-1158
9. Buscemi N., Vandermeer B., Hooton N., et al. Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. Br Med J 332 (2006) 385-393
10. Voderholzer U., Riemann D., Hornyak M., et al. A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects. Eur Arch Psychiatry Clin Neurosci 251 (2001) 117-123
11. Hicks J.A., Argyropoulos S.V., Rich A.S., et al. Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression. Br J Psychiatry 180 (2002) 528-535